Overview
Charles W. Flexner, M.D., is Professor of Medicine in the Divisions of Clinical Pharmacology and Infectious Diseases, and Professor of Pharmacology and Molecular Sciences in the Johns Hopkins University School of Medicine. He is also Professor of International Health in the Johns Hopkins University Bloomberg School of Public Health. Dr. Flexner is an expert on the basic and clinical pharmacology of drugs for HIV/AIDS and related infections, including viral hepatitis and tuberculosis. His scientific contributions include work on the important roles of pharmacokinetic enhancement, adherence, and dosing frequency in the long-term management of HIV/AIDS. He has published extensively on anti-infective drug transport and metabolism, and metabolic drug interactions. Dr. Flexner is currently the Chief Scientific Officer of the Institute for Clinical and Translational Research at Johns Hopkins. He also serves as Associate Vice-Chair for Academic Fellowship Programs in the Department of Medicine, and Associate Director of the Graduate Training Programs in Clinical Investigation of the Johns Hopkins University School of Medicine and Bloomberg School of Public Health. Dr. Flexner is the Principal Investigator of the Long-Acting Extended Release Antiretroviral Research Resource Program (LEAP), and Co-Principal Investigator of the Johns Hopkins University AIDS Clinical Trials Unit (ACTU) supported by the NIH. He served as President of the American Federation for Medical Research (AFMR) in 1999-2000, and was President of the AFMR Foundation from 2001-2002. He is a member of the editorial board of 10 scientific journals. He currently serves as a consultant to the Bill and Melinda Gates Foundation and the Clinton Health Access Initiative, and served as a consultant on FDA reform to the United States House of Representatives.
Dr. Flexner is highly rated in 1 condition, according to our data. His top areas of expertise are HIV/AIDS, Hepatitis, and Hepatitis C.
His clinical research consists of co-authoring 92 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.
Residency
Specialties
Licenses
Board Certifications
Fellowships
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
Locations
1800 Orleans Street, Baltimore, MD 21287
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
Johns Hopkins Outpatient Center
Dr. Brent Petty is a Professor of Medicine at the Johns Hopkins University School of Medicine. He holds a secondary appointment in Pharmacology and Molecular Sciences. Dr. Petty’s areas of expertise include clinical pharmacology and general internal medicine. He received his M.D. from the University of Utah. Dr. Petty’s research interests include quality improvement, antimicrobial chemotherapy, hospital-based medical practices, and internal medicine with ophthalmologic clinical trials. At Johns Hopkins, Dr. Petty serves as chair of the Pharmacy and Therapeutics Committee, the Clinical Quality Improvement Committee, the Continuity of Care Subcommittee. He co-chairs the Utilization Review Committee and the Order Set Review Committee. He is a member of the Society of General Internal Medicine. His top areas of expertise are Familial Hypertension, Hypertension, Glucocorticoid-Remediable Aldosteronism, and Juvenile Temporal Arteritis.
Frequently Asked Questions about Dr. Charles W. Flexner
How do I make an appointment with Dr. Charles W. Flexner?
You can book an appointment with Dr. Charles W. Flexner by calling their office at 410-955-5000. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Charles W. Flexner a top-rated expert for HIV/AIDS?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Charles W. Flexner is classified as an Distinguished expert for HIV/AIDS, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Charles W. Flexner specialize in?
While Dr. Charles W. Flexner is a Pharmacology, they have specific expertise in HIV/AIDS, Hepatitis, and Hepatitis C. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Pharmacology.
Does Dr. Charles W. Flexner participate in research or clinical trials?
Yes. Dr. Charles W. Flexner has published 92 articles and abstracts on conditions like HIV/AIDS. You can view a list of Dr. Charles W. Flexner's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Charles W. Flexner accept my insurance?
Dr. Charles W. Flexner accepts most major insurance plans, including Aetna and CareFirst. We recommend calling the office directly at 410-955-5000 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- HIV/AIDSDr. Flexner isDistinguished. Learn about HIV/AIDS.
- Experienced
- HepatitisDr. Flexner isExperienced. Learn about Hepatitis.
- Hepatitis CDr. Flexner isExperienced. Learn about Hepatitis C.